Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES

NANot yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

November 28, 2025

Study Completion Date

December 1, 2025

Conditions
MelasmaPost-acne Hyperpigmentation
Interventions
DRUG

a combination serum containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES

Subjects were randomized to receive a combination serum The combination serum contained Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES. applied twice daily, following QS-Nd:YAG 1064 nm low-fluence laser treatment. Clinical evaluations were conducted at baseline and at Weeks 1, 2, and 4 post-laser to assess pigmentation improvement, erythema, and overall skin condition.

DRUG

2% hydroquinone cream

Subjects were randomized to received 2% hydroquinone cream, applied once daily at night, following QS-Nd:YAG 1064 nm low-fluence laser treatment. Clinical evaluations were conducted at baseline and at Weeks 1, 2, and 4 post-laser to assess pigmentation improvement, erythema, and overall skin condition.

Trial Locations (1)

10410

Gatot Soebroto Central Army Hospital, Jakarta Pusat

All Listed Sponsors
lead

Dr.dr.Irma Bernadette, SpKK (K)

OTHER